- Home
- VATE vs RLYB Comparison
VATE vs RLYB Comparison
Compare VATE & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- RLYB
- Stock Information
- Founded
- VATE 1994
- RLYB 2018
- Country
- VATE United States
- RLYB United States
- Employees
- VATE N/A
- RLYB N/A
- Industry
- VATE Metal Fabrications
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- RLYB Health Care
- Exchange
- VATE Nasdaq
- RLYB Nasdaq
- Market Cap
- VATE 82.6M
- RLYB 45.2M
- IPO Year
- VATE 1996
- RLYB 2021
- Fundamental
- Price
- VATE $5.28
- RLYB $0.95
- Analyst Decision
- VATE
- RLYB Buy
- Analyst Count
- VATE 0
- RLYB 6
- Target Price
- VATE N/A
- RLYB $8.10
- AVG Volume (30 Days)
- VATE 47.9K
- RLYB 105.7K
- Earning Date
- VATE 11-06-2024
- RLYB 11-07-2024
- Dividend Yield
- VATE N/A
- RLYB N/A
- EPS Growth
- VATE N/A
- RLYB N/A
- EPS
- VATE N/A
- RLYB N/A
- Revenue
- VATE $1,231,500,000.00
- RLYB $598,000.00
- Revenue This Year
- VATE N/A
- RLYB N/A
- Revenue Next Year
- VATE N/A
- RLYB N/A
- P/E Ratio
- VATE N/A
- RLYB N/A
- Revenue Growth
- VATE N/A
- RLYB N/A
- 52 Week Low
- VATE $3.25
- RLYB $0.93
- 52 Week High
- VATE $13.00
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- VATE 46.38
- RLYB 37.53
- Support Level
- VATE $5.09
- RLYB $0.93
- Resistance Level
- VATE $6.48
- RLYB $1.24
- Average True Range (ATR)
- VATE 0.47
- RLYB 0.08
- MACD
- VATE -0.12
- RLYB -0.02
- Stochastic Oscillator
- VATE 13.48
- RLYB 6.45
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.